Clal Insurance Enterprises Holdings LTD Biomarin Pharmaceutical Inc Transaction History
Clal Insurance Enterprises Holdings LTD
- $11.1 Billion
- Q4 2024
A detailed history of Clal Insurance Enterprises Holdings LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Clal Insurance Enterprises Holdings LTD holds 16 shares of BMRN stock, worth $1,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$1,022% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
645Shares Held
179MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.45 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.23 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.21 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$889 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$671 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...